Startseite>>Signaling Pathways>> Others>>AGI-24512

AGI-24512

Katalog-Nr.GC33019

AGI-24512 ist ein potenter Hemmer der Methioninadenosyltransferase 2α (MAT2A) mit einem IC50 von 8 nM. AGI-24512 lÖst eine DNA-Schadensreaktion aus. AGI-24512 kann die Proliferation von MTAP-deletierten Krebszellen in vitro blockieren. AGI-24512 kann fÜr die Erforschung von Krebserkrankungen verwendet werden.

Products are for research use only. Not for human use. We do not sell to patients.

AGI-24512 Chemische Struktur

Cas No.: 2201066-53-5

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
556,00 $
Auf Lager
5mg
506,00 $
Auf Lager
10mg
782,00 $
Auf Lager
50mg
2.528,00 $
Auf Lager
100mg
3.631,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

AGI-24512 is a methionine adenosyltransferase 2A (MATA2 ) inhibitors useful for treatment of cancer. AGI-24512 blocks growth of MTAP-deleted cancer cells in vitro.

[1]. Agios. Targeting MAT2A in MTAP-deleted Cancers. Presented at the American Association for Cancer Research (AACR) Annual Meeting, April 14-18, 2018, Chicago, IL, USA

Bewertungen

Review for AGI-24512

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AGI-24512

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.